(Q50727804)
Statements
Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria. (English)
1 reference
Marcus Maurer
1 reference
Martin Metz
1 reference
Tatevik Ohanyan
1 reference
Martin K Church
1 reference
1 March 2014
1 reference
150
1 reference
3
1 reference
288-290
1 reference
Identifiers
1 reference